CustomFlex, by HumanOptics AG, is the first stand-alone prosthetic iris in the US, following its approval by the FDA.

The surgically implanted device will be available for adults and children whose iris is completely missing or damaged whether due to a congenital condition called aniridia or due to other damage to the eye.

A rare genetic disorder

Congenital aniridia is a rare genetic disorder in which the iris is completely or partially absent.

It affects approximately 1 in 50,000–100,000 people in the US.

The iris controls the amount of light entering the eye, and those with aniridia have sensitivity to light and other severe vision problems.

Reduces sensitivity to bright light and glare

In clinical trials, more than 70% of patients reported significant decreases in light sensitivity and glare as well as an improvement in health-related quality of life following the procedure, and 94% of patients were satisfied with the artificial iris’s appearance.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The CustomFlex Artificial Iris provides a novel method for treating iris defects that reduces sensitivity to bright light and glare.

It also improves the cosmetic appearance of the eye in patients with aniridia, offering patients an opportunity to improve how they see and how they are seen.